Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The FDA approved Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease who are also overweight in March 2024, which opened the door for Medicare coverage in that specific population
Dosing charts can serve as quick references to help mitigate confusion
Contact your provider if your vial expires before you finish it
Information Type Research Article Information British Journal of Nutrition , Volume 130 , Issue 10 , 28 November 2023 , pp
US$ 23.55
US$ 23.19
US$ 21.83
US$ 24.01
US$ 28.04
US$ 28.20
